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A magnesium factory, situated in the inner
part of the Frierfiord in southern Norway,
produces considerable amounts of
organochlorine compounds such as poly-
chlorinated biphenyls (PCBs), polychlori-
nated dibenzo-p-dioxins (PCDDs), and
polychlorinated dibenzofurans (PCDFs)
during the production of metallic magne-
sium (Fig. 1). As much as 50-100 kg
TCDD toxic equivalents (TEQs) may have
been discharged to the Frierfjord during the
past 35 years (1). As part of the National
Program on Pollution Monitoring,
PCDDs/PCDFs, PCBs, and non-ortho-
PCBs have been monitored in sediments
and marine organisms at various distances
from the source since 1986, 1989-1990,
and 1992, respectively (2-4). In spite of a
reduction in the emissions of organochlo-
rine compounds by more than 98% from
1990 to 1992 (1), considerable amounts of
PCDDs and PCDFs are still observed in
most marine organisms of the area.
Restrictions on commercial fishing and rec-
ommendations to the general public to
reduce consumption of fish and shellfish
have been established for the contaminated
fiord area. However, the area is popular for
recreational purposes, and some residents
still catch and consume considerable
amounts of local fish and shellfish.
Particularly during the summer and
autumn, the crab species Cancerpagurus is
a popular food item in this area. These
crabs contain high concentrations of
organochlorine compounds, revealing the
characteristic isomer pattern ofthe magne-
sium process (5) with tetra- to hexa-CDFs
being the predominant PCDD/PCDF
congeners and decachlorobiphenyl (PCB-
209) the most abundant PCB congener.
PCDDs, PCDFs, and PCBs are com-
plex mixtures of persistent lipophilic sub-
stances and tend to accumulate in marine
and terrestrial food chains. The general
population is mainly exposed to these sub-
stances through fatty food, leading to a
background body burden of these sub-
stances (6-8). People consuming large
amounts of contaminated seafood may
have elevated concentrations of
organochlorine compounds in their tissues
compared to the general population
(9-14). Due to low biodegradation and
excretion in humans, these substances
accumulate in the body fat, and their con-
centrations reflect external exposure
(6-8,15,16). Cumulative exposure has
been assessed by analyzing adipose tissue,
human milk, and/or blood (17-20).
The patterns of PCDDs, PCDFs, and
PCBs in humans do not directly reflect the
patterns of discharge to the environment
owing to differences in physical properties,
e.g., lipophilicity and volatility, and
biodegradability of the individual com-
pounds in the food chain. Of the
PCDD/PCDF congeners, the 2,3,7,8-sub-
stituted PCDD and PCDF congeners are
the most resistant to metabolism and are
generally the only congeners found in
human tissue (7,8). The hepta- and octa-
CDD congeners are by far the most abun-
dant in samples from the general popula-
tion (8). In contrast, fish and other organ-
isms from the aquatic environment usually
contain quite low concentrations of these
congeners (21,22).
For risk assessment purposes and to
assist in risk management, the concept of
toxic equivalency factors (TEFs) for the
2,3,7,8-substituted congeners has been
developed to express the toxic potency of
complex mixtures of PCDDs/PCDFs in
biological samples by a single value, the
2,3,7,8-TCDD toxic equivalent (TEQ)
(23,24). In addition, several of the non-,
mono-, and di-ortho-substituted PCBs,
which induce effects similar to those caused
by PCDDs and PCDFs, have been given
provisional TEF values (25). Even though
the application of the proposed TEFs to
health risk assessment has been criticized,
particularly for the PCBs (26), they are
widely used for risk management.
The objective of the present study was
to assess the role of consumption of crabs
from the contaminated fjord area for the
exposure to PCBs, PCDDs, and PCDFs.
We therefore determined blood concentra-
tions of these compounds in 24 male crab
consumers and 10 referents and recorded
information on crab consumption and fish-
ing site as well as consumption offish and
other food items to answer the following
questions: 1) Does the consumption of
crabs from the Frierfjord area lead to
increased body burdens of PCDD/PCDF
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and PCB compounds? 2) Are the patterns
for PCDDs/PCDFs and PCBs found in
human blood changed by the exposure
through crab consumption? 3) Do expo-
sure estimates based on measured blood
concentrations agree with those based on
reported crab intake? 4) What is the indi-
vidual exposure level compared to present
recommended tolerable intake of toxic
equivalents?
Materials and Methods
Study group and sample collection. It is
well documented that the body burden of
PCDD/PCDF and PCB compounds
increases with age and for women decreases
with the number of breastfed children
(7,18,27). To avoid variation ofbody bur-
den with age and sex, we restricted the
study to male subjects in a relatively close
age range. The study was approved by the
Regional Committee of Medical Research
Ethics, and informed consent was obtained
from all participants. A total of 34 male
volunteers, age 40-54 years, participated in
the study. All subjects were living in the
Frierfjord area of Norway. Male crab con-
sumers (high and moderate intake) were
recruited nonrandomly through announce-
ments in the newspapers and other media.
Of the 24 crab consumers, 20 had eaten
crabs for more than 10 years, 2 for 5-10
years, and 2 did not report the duration of
crab consumption. The male referents were
drawn randomly from the Register of
Population. Blood was sampled after
overnight fasting. About 250 ml venous
blood was drawn from each subject into
thoroughly cleaned glass bottles (Duran,
Schott, Germany) and kept frozen at -20°C
until analyzed. A questionnaire including
information on crab and fish consumption,
intake ofother fatty food items, and other
relevant factors was completed by each
donor. All subjects reported being healthy.
Information concerning the subjects ofthe
three groups is summarized in Table 1.
Standards and chemicals. Acetone was
glass-distilled grade and all the other organ-
ic solvents were pestiscan grade from
Labscan (Dublin, Ireland) or Merck
(Darmstadt, Germany). Sulfuric acid
(Scanpure, 98.3%) and nitric acid
(Scanpure, 65%) were purchased from
Chem Scan A/S (Elverum, Norway). The
'3C12-labeled PCB-77, PCB-126, PCB-
169, and 2,3,7,8-substituted PCDDs and
PCDFs as well as the native PCDDs and
PCDFs and 37CI-2,3,7,8-TCDD were
from Cambridge Isotope Laboratories
(Woburn, Massachusetts). The normal
PCB standards were purchased from
Cambridge Isotope Laboratories or from
Restek (Sulzbach, Germany). Silica gel,
aluminum oxide, sodium sulfate, and
potassium hydroxide were from Merck and
the activated carbon AX-21 was from
Anderson Development Company (Adrian,
Michigan). All adsorbents were prepared as
previously described by Smith et al. (28)
and Oehme et al. (21). All glassware for
organochlorine analysis was washed in
2.5% RBS detergent and distilled water,
then heated in an oven at 500°C overnight.
Determination ofPCDDs, PCDFs, and
non-ortho PCBs. The extraction was per-
formed after a method described by Papke
et al. (29). We packed 100 g of Hydro-
matrix (plankton marine diatomite; Varian
Sample Preparation Products, Harbor City,
California) and 50 g ofsodium chloride in
alternating layers into glass columns (30 cm
x 5 cm i.d.). Thereafter, the adsorbents
were washed with 375 ml of n-heptane/iso-
propanol (3:2, v/v) and 375 ml of methyl-
ene chloride and dried at 50°C overnight.
We transferred 45-50 g ofwhole blood,
spiked with internal standards and diluted
with water and ethanol (1:0.66:0.13, v/v/v)
to the column. The extraction was per-
formed by eluting with 650 ml of n-hep-
tane/isopropanol (3:2, v/v). The eluate was
concentrated under a gentle stream ofpuri-
fied nitrogen and dissolved in about 2 ml of
cyclohexane. The extract was transferred to
glass columns (10 cm x 2 cm i.d.) filled
with sodium sulfate for removal ofany pre-
cipitated salt and evaporated to dryness
with a gentle stream of nitrogen before
gravimetric determination ofthe lipids.
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Figure 1. Map of Norway and the Frierfjord fjord area, with concentrations of PCDDs/PCDFs (pg TEO/g
wetweight) in crab hepatopancreas obtained during the National Program on Pollution Monitoring 1992
(3) atthe regular sampling sites Ato F.
Table 1. Mean and range of age, body mass index(BMI), crab and fish consumption, % fat in the blood
samples, and polyunsaturated fattyacids(PUFA) in serum phosphatidylcholine forthe three groups
Referents Moderate intake High intake
(n=1O) (n=15) (n=9)
Age (years) 46.7(41-50) 45.33(40-54) 46.22(41-52)
BMI (kg/M2) 25.4(22.2-30.7) 26.2(21.7-32.7) 27.3(21.5-30.9)
Crab intake (no./year) 0 11.9(10-38) 77.2(40-150)
Crab equivalents (no/year) 0 19.6(10-115) 93.2(24.8-156)
Fish intake (meals perweek) 1.1 (0.5-2.5) 1.4(0.25-2.5) 1.8(0.5-3.5)
Extracted fatfrom whole blood (weight%) 0.39(0.29-0.48) 0.37 (0.28-0.55) 0.47 (0.33-0.69)
In-3 PUFA(weight%) 11.72(8.95-16. 01) 12.98(8.3-20.46) 11.64(8.66-15.5)
In-6 PUFA (weight %) 35.25 (30.43-38.89) 34.31 (24.55-38.8) 35.88 (31.32-38.88)
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The clean-up was carried out in a mul-
ticolumn system according to a slight mod-
ification ofthe method described by Smith
et al. (28). In brief, the fat extract was
passed through two columns in series using
a total of 825 ml of dichlorometh-
ane/cyclohexane (1:1, v/v) followed by 50
ml of dichloromethane/methanol/benzene
(15:4:1, v/vlv). The first column contained
sodium sulfate, potassium silicate, and sili-
ca gel, and the second contained activated
carbon (AX-21) dispersed on glass fibers.
PCDDs and PCDFs were removed from
the carbon column by reversed elution with
100 ml of toluene. The crude dioxin frac-
tion was further purified by chromatogra-
phy using two Pasteur pipettes in series
filled with acidic silica and basic alumina,
respectively. 37Cl-2,3,7,8-TCDD was
added to the final extract as a recovery con-
trol standard and 10 pl of n-nonane as a
keeper before concentrating to about 15 pl.
The GC-HRMS instrument consisted of
a VG AutoSpec high-resolution mass spec-
trometerwith Opus Quan software program
and a Hewlett Packard 5890 gas chromato-
graph with a DB-5 MS capillary column, 60
m x 0.25 mm i.d., 0.1-pm film thickness
(J&W Scientific, Folsom, California).
Helium was used as carrier gas with a linear
velocity of28 cm/sec (at 200°C). Injections
were performed in the splitless mode using
an HP 7673 A autosampler. The injector
temperature was 280°C. For dioxins, the
initial column temperature was 90°C (1-
min hold), then 1970C at 20°C/min, then
2500C at 2°C/min, and thereafter 3000C (5-
min hold) at 5°C/min. For non-ortho-PCBs,
the initial column temperature was 130°C
(1-min hold), then 2000C at 20°C/min,
then 212°C at 0.6°C/min, and thereafter
300°C (10-min hold) at 5°C/min. Selected
ion detection was carried out in the electron
impact mode with an MS ion source tem-
perature of2500C, an electron energy of35
eV, and a resolution of 10,000 and 9,000
for the dioxins and the non-ortho-PCBs,
respectively. Dwell time for each ion was 80
msec. Perfluorokerosene was used to provide
suitable lock masses. The transfer line was
held at 280°C.
Quantitation. 13C-labeled analogues of
the 2,3,7,8-substituted PCDDs and PCDFs,
except OCDF, were added as internal stan-
dards before extraction of samples. 37Cl-
2,3,7,8-TCDD was added to the final extract
as a recoverycontrolstandard. Multilevel cali-
bration was performed. Detection limits were
0.5-8 pg/g fat, depending on the congener.
Recoveries of the internal standards were
between 70 and 100%.
For non-ortho-PCBs, 13C-labeled ana-
logues were used as internal standards.
Multilevel calibration was performed before
or directly after each analysis series. PCB-
189 was added to the final extract to mea-
sure the recovery of the 13C-labeled stan-
dards. Detection limits were 1-7 pg/g fat
for different congeners and sampling condi-
tions. Recoveries were between 50 and
80%. PCB-77 could not be quantitated due
to coelution with contaminants. However,
this non-ortho-substituted PCB does not
contribute significantly to the dioxin-relat-
ed toxicity as both the concentration in
human samples is generally low (16,19),
and its WHO-TEF value is very small.
Determination ofPCBs. Mono- and
multi-ortho-PCBs were extracted from 15
ml ofwhole blood by the same extraction
procedures as the PCDDs and PCDFs and
the non-ortho-PCBs. The lipid extracts
were dissolved in cyclohexane (about 0.1 g
lipid/ml) and treated twice with an equal
volume of concentrated sulfuric acid to
remove the major part of the lipids and
other interfering organic compounds. The
sulfuric acid phase was reextracted with
cyclohexane. Additional purification was
performed by chromatography on basic
alumina using hexane/dichloromethane
(80/20, v/v) as an eluent. The organic
phase was reduced to 1 ml by a gentle
stream ofpurified nitrogen.
GC analysis was performed with a
Perkin Elmer 8700 gas chromatograph
equippedwith an electron capture detector,
an AS-8300 autosampler and a PE Nelson
Model 1020 personal integrator (Perkin-
Elmer Corp., Beaconsfield, UK). Hydro-
gen was used as carrier gas with a linear
velocity of 28 cm/sec (at 100°C).
Argon/methane (5%) was used as make-up
gas with a flow rate of 50 ml/min. Injector
temperature was 2700C and the detector
was operated at 3300C. A DB-5 capillary
column, 50 m x 0.25 mm i.d., 0.25 pm
film thickness (J&W Scientific, Folsom,
California) was temperature-programmed
from 600C (1-min hold) to 2000C at
20°C/min, then to 280°C (10-min hold) at
2.0°C/min.
PCB-116 was used as an internal stan-
dard for the mono-ortho and multi-ortho
PCB congeners (IUPAC nos. 28, 52, 74,
99, 105, 118, 128, 138, 153, 156, 157,
170, 180, 187, 194, 206, 209). Detection
limits for the multi-ortho- and mono-ortho-
substituted PCBs were 0.01 to 0.05 ng/g
fat, depending on the congener.
Toxic equivalencyfactors. Concentra-
tions expressed in 2,3,7,8-TCDD toxic
equivalents (TEQs) were calculated accord-
ing to a model proposed by a Nordic
expert group (30) for PCDDs/PCDFs and
by an expert group convened by the World
Health Organization (WHO) (25) for the
PCBs. The Nordic model differs from the
international TEFs (31) in that the TEF
for 1,2,3,7,8-penta-CDF is 0.01 (i.e., a fac-
tor of 5 lower than in the international
model).
Quality assurance oforganochlorine
compound analysis. All samples were ana-
lyzed coded. For each set offive samples, a
method blank was prepared using the same
extraction and preparation procedures.
New glass columns and adsorbents were
used for each sample to avoid cross-conta-
mination. For PCDDs/PCDFs, most blank
samples contained less than 1 pg ofall ana-
lytes, except for the ubiquitous octachloro-
dibenzo-p-dioxin (OCDD). The repeatibil-
ity ofthe entire method, the recovery rates
of isotopically labeled internal standards,
and the detection limit for the method
were in good agreement with those values
reported by Papke et al. (29), who used the
method successfully in WHO interlabora-
tory control studies.
For PCBs, recovery rates for all quanti-
tated congeners throughout the procedure
were in the range of45-80%. Good analyti-
cal quality for determination ofPCBs in fish
oil and of PCDDs/PCDFs in human milk
was confirmed by successful participation in
interlaboratory quality control studies orga-
nized by the Swedish Environmental
Protection Agency in 1991 and by WHO!
EURO in 1991-1992, respectively.
Determination offatty acids. We
allowed 10 ml ofvenous blood to clot and
immediately separated serum by centrifuga-
tion, cooled it, and froze it within 6 hours
at -70°C until analysis. The concentration
of fatty acids in plasma phospholipids was
measured essentially as described elsewhere
(32). Briefly, plasma lipids were extracted
with n-butanol (33) and phosholipids were
isolated from the lipid extracts by column
chromatography on Sep-Pak C18 cartridges
(Waters Corp., Milford, Massachusetts).
Diheptadecanoylglycerophosphocholine
and butylated hydroxytoluene were added
as internal standard and antioxidant,
respectively. Phospholipids were trans-
methylated and quantitated by gas chro-
matography (34). A reference human
serum sample was included as a control to
monitor analytical performance. The day-
to-day coefficient of variation for 20:4 (n-
6), 20:5 (n-3), and 22:6 (n-3) fatty acids
were 3.8, 3.7, and 4.7%, respectively. The
results were quantitated as milligrams of
phospholipid fatty acid per liter ofserum.
Statistical analysis. Nonparametric
tests were chosen for statistical analysis
because lack ofnormality was found in sev-
eral distributions of PCB, PCDD, and
PCDF concentrations. The Mann-
Whitney U-test in the'statistical program
Statview SE (Abacus Concepts, Inc.
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Berkeley, California) was used to compare
groups. Significant difference was set at p
<0.05. Correlations were calculated using
the Pearson correlation coefficients.
Results
The crab consumers were divided into two
groups, a moderate-intake group (10-38
crabs per year) and a high-intake group
(>40 crabs per year). These two groups and
referents were compared with respect to
age, body mass index, fish intake, fat in
whole blood, and relative levels of22:5 (n-
6) polyunsaturated fatty acids (PUFA), total
n-3 PUFA, and total n-6 PUFA in blood
(Table 1). In addition to differences in crab
intake, there was a slight nonsignificant
increase in the intake of fish, particurlarly
for the high consumers ofcrabs. There were
no differences with respect to consumption
ofmilk and dairy products or other sources
of animal fat. There was no other signifi-
cant difference in age ofthe subjects, rang-
ing from 40 to 54 years, and no correlation
between the age and the level of PCDDs
and PCDFs in blood was observed.
In addition to the the number ofcrabs
eaten, exposure to organochlorine com-
pounds (OCs) is highly dependent on the
location ofthe fishing sites and which parts
ofthe crabs are consumed. The hepatopan-
creas of the crab has a high fat content
(about 15-20%) compared to the rest of
the crab meat and accordingly contains
most of the OCs. All but two of the sub-
jects in our study group reported eating
whole crabs, including the hepatopancreas.
There was a considerable decrease
(about 25 times) of PCDD/PCDF in crab
hepatopancreas from the inner part of the
fjord (site A), close to the magnesium fac-
tory, to sampling site F, about 35 km from
the source (Fig. 1). To account for this gra-
dient in organochlorine content ofcrabs as
a function of distance from the source, we
introduced equivalency factors according to
the relative PCDD/PCDF content of the
crab hepatopancreas. These factors ranged
from 10 at site A (corresponding to 1630
pg TEQ/g wet weight) to 0.36 at site F
(corresponding to 59 pg TEQ/g wet
weight). The reported number of crabs
consumed was then multiplied with the
factors closest to the reported fishing sites.
In cases where the fishing sites were at
approximately equal distances from two
monitoring sites, interpolated factors were
used. Crab equivalents consumed per year
in the different groups are given in Table 1.
Concentrations of 17 2,3,7,8-substitut-
ed PCDDs and PCDFs, given as mean,
median, and ranges, divided into three
groups according to the reported crab
intake, are listed in Table 2. Blood concen-
trations for many PCDD and PCDF con-
geners in crab consumers are significantly
raised compared to the referents, particular-
ly for the penta- and hexa-CDFs. The most
pronounced difference between the control
and high-intake groups (more than 14
times) was observed for 1,2,3,4,7,8-hexa-
CDF. There was also a significant increase
in the level of several PCDDs, mostly the
lower-chlorinated ones. In contrast, the
concentrations of hepta- and octa-CDDs
tended to decrease from the control to the
high-intake group, but not significantly.
In Figure 2, the profile of 2,3,7,8-sub-
stituted congeners in crab hepatopancreas
is compared with concentrations found in
the blood from persons with no and high
crab consumption. The PCDD/PCDF
profile in the high-intake group is clearly
influenced by the profile found in crab
hepatopancreas. The PCDD profiles ofthe
blood samples from both the high-intake
group and the referents are dominated by
octa-CDD which contributes little to the
sum ofPCDDs/PCDFs in crab hepatopan-
creas; however, this congener is clearly less
dominant in the crab eaters.
When plotting blood concentrations of
individual congeners against the intake of
crab equivalents, good linear correlations (r
Table2. Mean, (median), and range of PCDDs and PCDFs congeners in blood samples forthe three
groups ofmen with different crab intakea
Congener Refe
2,3,7,8-TCDD
1,2,3,7,8-PeCDD
1,2,3,4,7,8-HxCDD
1,2,3,6,7,8-HxCDD
1,2,3,7,8,9-HxCDD
1,2,3,4,6,7,8-HpCDD
1,2,3,4,6,7,8,9-OCDD
YPCDDs
PCDDs, Nordic-TEQs
2,3,7,8-TCDF
1,2,3,7,8,-PeCDF
2,3,4,7,8-PeCDF
1,2,3,4,7,8-HxCDF
1,2,3,6,7,8-HxCDF
2,3,4,6,7,8-HxCDF
1,2,3,7,8,9-HxCDF
1,2,3,4,6,7,8-HpCDF
1,2,3,4,7,8,9-HpCDF
1,2,3,4,6,7,8,9-OCDF
XPCDFs
PCDFs, Nordic-TEQs
EPCDDs/PCDFs
PCDDs/PCDFs, Nordic-TEQs
erents (n= 10)
3.6 (3.1)*
0.2-7.0
5.9 (5.6)*
0.5-10.6
2.4 (2.2)*
0.9-3.4
14.7 (14.2)*
2.7-24.5
4.3(3.8)
0.6-7.3
54.1 (34.7)
10.0-179.1
477.9 (470.3)
51.7-951.1
562.8 (532.5)
9.7 (8.7)
2.8 (2.9)
0.6-5.0
1.8(1.6)*
0-10.9
17.1 (15.5)*
4.9-33.5
8.7 (7.4)*
1.9-21.4
9.7 (7.7)*
2.3-21.9
4.3 (3.8)*
1.6-6.7
0.9 (0.9)*
0-1.0
18.0(13.3)
2.5-53.3
1.0(1.1)
ND-0.9
8.6 (6.1)
1.3-30.0
72.8 (60.2)
11.4(10.2)
631.1 (589.4)
21.1 (18.9)
Moderate intake (n= 15)
7.7 (6.8)
3-13.6
17.3 (15.0)**
6.9-34.8
8.0(6.3)
ND-30.1
27.6(24.8)
13.1-48.2
8.6 (6.7)
ND-43.5
45.5(39.8)
20.8-77.4
335.6(350.9)
157.1-40.4
450.3(450.3)
21.5 (18.8)
5.1 (4.1)
ND-12.7
7.2(6.3)
1.5-19.5
54.0 (52.8)**
17.6-111.9
54.9(55.2)**
10.8-107.1
44.8 (46.9)**
8.8-90.3
8.9 (7.9)
ND-33.0
3.6(1.1)
ND-34.3
44.3 (46.8)**
0.1-117.5
4.8(1.5)
ND-46.2
13.4(7.4)
ND-93.9
241.0 (230.1)
39.3(38.5)
691.3(680.4)
60.8 (57.3)
High intake (n=9)
11.0 (9.2)
6.3-22.4
28.3 (24.8)
15.4-45.13
10.8(11.4)
4.0-17.4
39.1 (34.4)
16.9-63.7
9.9 (8.8)
5.9-20.9
33.3 (31.1)
16.9-63.7
266.8 (284.9)
104.2-362.9
399.3(404.6)
31.8 (27.7)
7.2(6.4)
1.7-16.5
13.4(13.3)
1.29-34.59
102.2 (103.6)
51.5-147.8
130.1 (130.2)
34.3-232.6
102.7 (77.8)
26.6-217.1
14.3 (10.9)
3.2-29.4
2.3 (2.0)
0-5.4
93.0 (92.6)
26.8-201.2
2.6 (2.4)
ND-5.3
5.4(6.1)
2.1-8.8
473.3(446.3)
77.9 (75.7)
872.5 (850.9)
109.6(103.4)
ND, not dectected.
aConcentrations are given in pg/g fat.
*Significantly different as compared with the moderate-intake group (p<0.05 by Mann-WhitneyU-test).
**Significantly different as compared with the high-intake group (p<0.05 by Mann-Whitney U-test).
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>0.6) were obtained for 2,3,4,7,8-penta-
CDF, 1,2,3,4,7,8-hexa-CDF, and
1,2,3,6,7,8-hexa-CDF, as well as TCDD
and penta-CDD. The correlations were
lower (r = 0.4-0.6) for 2,3,7,8-tetra-CDF,
1,2,3,7,8-penta-CDF, 1,2,3,4,7,8-hexa-
CDF and 2,3,4,6,7,8-hexa-CDF (not
shown).
Mean, median, and ranges of blood
concentrations of 2 non-ortho-PCBs, 4
mono-ortho-PCBs, and 13 other PCBs for
the three study groups are given in Table 3.
Almost all PCB congeners increased slightly
from the referents to the high-intake group
with significant increases for PCB-99, 128,
156, 157, 170, 180, 194, 206, and 209.
However, no significant correlation was
observed between the concentrations of
sum PCBs (dominated by PCB-138, 153,
170, and 180) and crab intake (r= 0.19).
A comparison of the PCB profiles in
crab hepatopancreas (3) from the Frierfiord
area and in blood samples of the referents
and the high-intake group is shown in
Figure 3. There are only minor differences
in the profiles for the referents and the
high-intake group, and there is little agree-
ment between the blood profiles and the
profile found in crabs. The high concentra-
tion of PCB-209 found in crabs from the
Frierfjord area is not reflected in the blood
ofthe crab consumers.
The contribution ofdifferent dioxinlike
compounds to the total TEQs for the three
study groups is presented in Figure 4.
While there is only a slight increase in
TEQs for the PCBs with increasing crab
consumption, the PCDD/PCDF-related
TEQs are about five times higher in the
high-intake group compared to the refer-
ents. Thus, the relative contribution of
PCBs to the total TEQs drops from 65%
in the referents to about 35% in the high-
intake group.
When plotting the PCDD/PCDF-
related TEQs in blood against the intake of
crab equivalents, a good correlation was
observed (Fig. 5, r = 0.75). When only
numbers ofcrabs were used, the correlation
factor was 0.68, and several of the data
points for subjects who caught crabs close
to extreme sites B and F (see Fig. 1) were
remote from the regression line. This
emphasizes the usefulness of crab equiva-
lents, which accounts for the gradient in
PCDD/PCDF concentrations ofcrabs as a
function ofthe distance from the source.
Based on the measured blood concen-
trations, we wanted to estimate the total
body burden ofPCDDs /PCDFs, expressed
as TEQs. We assumed that the whole dose
is evenly distributed in the body fat com-
partment (35-37 The percentage ofbody
fat was calculated from the body mass index
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Figure 3. Profile of PCBs in blood samples from referents and high-intake group compared to the profile in
crab hepatopancreas from sampling site D.
and age, according to an empirical equation
developed by Deurenberg et al. (38). The
mean body burdens and ranges for the ref-
erents, the moderate-intake group and the
high-intake group were 5.2 (1.1-11.5),
15.5 (5.5-30.4), and 28.7 (12.7-45.9)
ng/kg body weight, respectively. Based on
these calculated body burdens, we wanted
to estimate the average weekly intake.
Several assumptions were made. Although
the kinetics differ between the individual
compounds (39), PCDD/PCDF concentra-
tions were expressed as a single number, the
TEQ. We use a single-compartment model
with first-order kinetics. Several half-life
values for 2,3,7,8-TCDD elimination have
been reported varying from 3 to 11 years
(40,41). We assumed an average half-life of
7 years and assumed that PCDD/PCDF
concentrations in the subjects had reached a
steady state. Assuming complete absorp-
tion, we used the following equation to cal-
culate the meanweeklyintake:
WI C x BF[x In 2
L7(52 weeks)J
where WI = weekly intake (pg/kg body
weight/week), C = concentration of
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Table 3. Mean, (median) and range of PCB congeners in blood samples forthe three groups of men with
different crab intake8
Congener
2,4,4'
2,2',5,5'
2,4,4-,5
2,2',4,4',5
2,2',3,3',4,4'
2,2',3,4,4',5'
2,2-4,4',5,5'
2,2',3,3',4,4',5
2,2,3,4,4,5,5
2,2',3,4',5,5',6
2,2',3,3',4,4',5,5
2,2-,3,3-,4,4',5,5',6
2,2',3,3',4,4',5,5',6,6'
2,3,33,4,4'
2,3',4,4',5
2,3,3',4,4',5
2,3,3',4,4',5
3,3.4,4'
3,3-4,4-,5
3,3'4,4-,5,5'
IPCBs
IUPAC no. Referents (n= 10) Moderate intake (n= 15)
28 2.9 (3.3) 4.1 (4.8)
1-4.3 1.3-9.4
52 0.4 (0.5) 0.7 (0.6)
ND-0.6 ND-1.9
74 14.1(15.5) 11.6 (12.3)
5.2-20.5 0.7-24.6
99 12.1 (11.1)* 12.1 (10.1)
4.5-18.2 3.8-21.8
128 1.5 (1.4)* 1.5(1.4)
1.1-2.8 0.3-2.8
138 287.4 (223.9) 329.8 (289.2)
145.9-359.5 220.1-478.1
153 385.3 (361.9) 438.8 (390.3)
188.6-553.6 236.1-699.6
170 105.5 (100.4)* 124.7 (116.7)
63.9-141.9 34.9-229.0
180 264.3 (237.9)* 283.5 (256.5)
135.3-346.0 239.9-610.9
187 34.1 (36.6) 39.8 (25.1)
5.6-25.4 1.4-38.9
194 1.6 (0.53)* 4.2(4.3)
ND-4.8 ND-9.0
206 1.5 (1.4)* 3.6 (3.5)
0.3-0.9 ND-11.9
209 0.9 (1.2)* 2.1(1.8)
0-2.3 1.4-4.7
105 11.7 (9.2) 17.5 (18.3)
1.9-19.9 4.3-49.8
118 29.3 (32.2) 35.6(34.2)
11.1-42.6 2.3-72.1
156 23.7 (26.2)* 31.5 (29.7)
8.7-34.6 6.7-46.3
157 4.2(4.4) 3.6(3.5)
1.9-6.0 0.4-9.6
77 NA NA
126b 93.4 (100.7) 93.03 (92.6)
8.02-173.2 14.8-222
169b 70.1 (72.7) 94.7 (92.8)
4.9-108.9 18.3-199.1
1180.6 (1067.8) 1344.2(1202.5) 1481.4 (1365.9)
High intake (n= 9)
4.2 (3.2)
1.8-10.4
0.6 (0.6)
ND-0.9
17.5 (18.3)
4.2-21.8
16.1 (14.7)
5.1-23.9
3.7 (3.3)
1.9-6.8
334.2 (299.1)
180.7-516.4
479.2 (417.3)
289.2-751.5
140.5 (133.4)
86.6-314.8
317.4 (315.9)
239.0-650.9
46.8 (44.2)
8.0-29.2
6.2 (5.6)
3.1-11.4
3.2 (4.2)
ND- 5.61
3.4(4.7)
1.2-9.9
21.9 (19.9)
11.7-41.9
41.7 (39.2)
38.9-74.8
37.4(35.6)
22.3-53.7
7.2 (6.5)
3.7-13.3
NA
94.5 (98.1)
20.2-286.8
119.6(89.7)
23.4-254.1
ND, not detected.
TConcentrations are given in ng/g fat, if not stated otherwise.
bValue in pg/g fat.
*Significantly different as compared with the high-intake group (p<0.05 by Mann-WhitneyU-test).
NA, not analyzed due to interfering compounds.
PCDD/PCDF in blood (pg/g fat), and BF =
body fat fraction (g/kg body weight). It is
obvious that this approach can only give a
rough estimate ofthe weekly intake, particu-
larly due to the assumption of a single half-
life for all PCDD/PCDF congeners.
Calculation ofintake ofPCDD/PCDF from
measured blood levels gives for the referents
a weekly intake of 9.7 (2-22) pg/kg body
weight (mean and ranges), for the moderate-
intake group 31 (10-61) pg TEQ/kg body
weight, and for the high-intake group 62
(24-114) pgTEQ/kgbodyweight/week.
We further calculated the yearly intake
ofPCDDs/PCDFs from crab consumption
using the differences between the blood
concentrations of the individual crab con-
sumers and mean blood concentrations of
the referents. The values were 63-317 ng
TEQ/year for the high-intake group and
2-244 ng TEQ/year for the moderate-
intake group. These values were compared
to estimates ofyearly intakes based on pre-
viously measured concentrations in crabs,
reported fishing site, and consumption.
The linear correlation coefficient was r =
120
m PCDFs _
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Figure 4. Mean blood concentrations (pg TEQs/g
fat) of non-ortho-, mono-ortho- and di-ortho-
PCBs, PCDDs, and PCDFs for the referents and
the two crab-consuming groups.
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Figure 5. Relationship between intake of crab
equivalents and blood concentrations of PCDDs
and PCDFs(pgTEQ/g fat) in 34subjects (r=0.75).
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Figure 6. Relationship between estimates of
PCDD/PCDF intakes (in ng TEQ/year) from crab
consumption using either PCDD/PCDF blood con-
centrations or reported crab consumption and
fishing site.
0.61 (Fig. 6). Given the uncertainty ofcrab
consumption over the years and reported
fishing sites, there is, except for a few sub-
jects, remarkably good agreement between
the two methods ofestimating the intake.
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To assess the intake offat from marine
sources in relation to the PCDD/PCDF
exposure, we determined the fatty acid pro-
file in serum phospholipids. Whereas the
concentration of n-3 PUFA represents the
intake of marine fat, n-6 PUFA is mainly
derived from plant sources (12,42,43). In
the present study, we did not find a correla-
tion between n-3 PUFA or the ratio of n-3
to n-6 PUFA and the number offish meals
per week nor the intake of crabs, which
were mostly consumed more than 6 months
before blood sampling. Consequently, we
have not been able to find any correlation
between the levels of n-3 PUFA and con-
centrations ofPCDDs/PCDFs.
Discussion
During magnesium production, PCDFs are
formed to a greater extent than PCDDS,
resulting in a concentration ratio between
XPCDFs to £PCDDs in the waste water of
about 10:1 (21). The characteristic pattern
for the tetra- and penta-CDF isomers is
nearly undisturbed in the crabs (5,21). For
the blood samples in our study, the ratio of
EPCDFs:IPCDDs increases with increas-
ing intake of crab equivalents (r = 0.699),
with a mean of 0.13 for the referents and
1.2 for the high-intake group. Recently,
Hansson et al. (44) demonstrated a similar
increase of the EPCDFs:XPCDDs ratio in
blood ofworkers from the same magnesium
production plant with the number ofyears
of employment in the plant giving a mean
of 0.21 for the control group and 1.1 for
the workers. This strongly indicates that
changes occur in the PCDD/PCDF blood
profile due to exposure to characteristic
contaminants from the magnesium produc-
tion process both in occupationally exposed
workers and in people consuming seafood
from the contaminated fjord area. This is
further substantiated by the facts that the
PCDD/PCDF profile in the high-intake
group clearly corresponds to the profile
found in crab hepatopancreas (Fig. 2) and
that good correlations are observed between
several PCDD/PCDF congeners in blood
and the individual crab intake. The relative
low content ofTCDF in blood ofthe high-
intake group could indicate that this con-
gener has a shorter half-life.
In general, a high abundance of octa-
CDD is observed in the fat fraction of
human tissues, but its source has not yet
been identified. Schecter et al. (8) reported
octa-CDD ranging from 50% to 80% of
the YPCDDs/PCDFs in blood samples
from the general population living in dif-
ferent parts ofthe world. This corresponds
well with the results of this study, where
octa-CDD accounted for 74% of all
PCDDs/PCDFs in the referents. In con-
trast, the relative contribution from octa-
CDD was reduced to 32% for the high-
consumer group due to the considerably
higher concentrations of PCDFs in blood
(Fig. 2), demonstrating the change in
PCDD/PCDF profiles that follows crab
consumption.
Levels of total PCDDs and PCDFs in
our referents (563 and 73 pg/g fat) are
comparable with mean concentrations of
461 and 85 pg/g fat for the control group
ofworkplace exposure study ofHansson et
al. (44) and with values of489 and 53 pg/g
fat reported in whole blood samples from
Germany by Papke et al. (45). Thus, the
mean blood concentrations of PCDF
found for our crab consumers (473 pg/g fat
in the high-intake group) were clearly dif-
ferent from both Norwegian and German
referents, but similar to those found in the
magnesium plantworkers (491 pg/g fat).
Previous studies from areas near the
Baltic Sea with fish as a main source of
dioxin exposure have reported strong corre-
lations between blood levels of n-3 PUFA
and dioxins as well as fish intake
(12,42,43). In contrast, we did not find
any association between n-3 PUFA and fish
intake. This might be explained by the pre-
dominant consumption oflean fish in our
study and the narrow range of fish intake
(Table 1) in a relatively small population.
Furthermore, the lack of a correlation
between reported crab intake and n-3
PUFA is probably due to the limited season
for crab consumption. Crabs are usually
caught and consumed about 4 months a
year, starting inAugust. The blood samples
were collected in June, just before the crab
season started. Because the half-lives of n-3
PUFA are quite short, an influence by for-
mer crab consumption on the n-3 PUFA
concentrations is not expected. As a conse-
quence, presuming that crab consumption
is the main source ofPCDD/PCDF expo-
sure, no correlation was found between n-3
PUFAand PCDDs/PCDFs in blood.
Recently we reported on the congener-
specific determination of PCBs in crabs
from the Frierfjord area (4). Sum PCBs in
the crabs, excluding PCB-209, was not
much above background levels found in
crabs from diffuse polluted areas along the
coast [0.5-1 pg/g fat (46)]. However, the
perchlorinated biphenyl PCB-209 showed a
high abundance in the crabs, ranging from
2.9 to 0.05 pg fat in a gradient from fishing
site A to F (27,28) (see Fig. 1). This con-
gener has been identified as one of the
major chlorinated components in thewaste-
water from the magnesium factory (46).
Surprisingly, the high concentrations of
PCB-209 found in crabs from the Frieriord
area are not reflected in the blood ofthe crab
consumers (Fig. 3; Table 3). This could be
due to limited bioavailibility (44. Studies on
mammals have shown that organochlorine
compounds with a log n-octanol/water parti-
tion coefficient (log Kow) >6.5 are poorly
absorbed in the gastrointestinal tract
(47-50). PCB-209, with a logI§w of9.6, is
thus expected to have alowdegree ofabsorp-
tion. Furthermore, the linear correlation
coefficient between £PCDDs/PCDFs and
£PCBs in the blood samples was low (r =
0.39). This fact and the similarity of PCB
profiles for the referents and the high-intake
group indicates that PCB exposure in our
study group is only increased somewhat by
crab consumption, but predominantly arises
from othersources.
Blood concentrations ofthe major PCB
congener, PCB-153 (189-554 ng/g fat in
referents), as well as some other congeners
(PCB-105, 118, 156 and 157), found in
our study are in good agreement with the
results obtained from control persons in a
Swedish study [PCB-153, 220-760 ng/g
fat for referents (11)]. On the other hand,
our results for non-ortho-PCBs (PCB-126:
8-173 ng/g fat and PCB-169: 5-109 ng/g
fat) seem to be considerably lower than for
the Swedish nonconsumers of fish (PCB-
126: 100-450 pg/g fat and PCB-169: 100-
340 pg/g fat).
The calculated mean PCDD/PCDF
exposure ofthe referents of9.7 pg/kg body
weight is in good agreement with an esti-
mated intake of about 8-10 pg TEQ/kg
body weight/week based on measurements
of PCDDs/PCDFs in different food items
in Norway (51). Consumption ofcontami-
nated crabs increases the total exposure to
PCDDs/PCDFs considerably. The average
total exposure calculated for the group with
moderate crab consumption is with 31
pg/kg body weight, close to the tolerable
weekly intake (TWI) (35 pg TEQ/kg body
weight) proposed by a Nordic Expert
Group (30,52), and only few subjects in
this group exceeded this value. In contrast,
nearly all subjects in the high-intake group
exceeded the Nordic TWI. However, only
two persons slightly exceeded the TWI of
70 pg TEQ/kg body weight recommended
by aWHO expert group (53).
The use of the TEF concept for PCBs
is controversial (26). However, based on
measured concentrations in blood (see Fig.
4), PCBs in the referents would contribute
twice as much as PCDDs/PCDFs to the
total TEQs. In the moderate-intake group,
PCBs and PCDDs/PCDFs would con-
tribute equally to the total TEQs, whereas
in the high-intake group PCDDs/PCDFs
would contribute twice as much as the
PCBs. With the inclusion of PCBs in the
calculation ofTEQs, the mean for the ref-
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erents would be close to the Nordic TWI,
whereas both groups of crab consumers
would exceed the TWI.
Conclusion
The present study shows that among male
recreational fishermen, consumption of
crabs from the contaminated Frierfjord
area is an important source of exposure to
PCDDs/PCDFs. This is based on two
findings: the PCDD/PCDF profile in
blood of the high-intake group is clearly
changed in the direction of that found in
crabs from this area, and the measured
blood concentrations of most
PCDDs/PCDFs correlate strongly with the
reported crab consumption and fishing
site. No other major source of exposure to
PCDDs/PCDFs could be identified
through the questionnaire. It appears that
the external exposure can be estimated
both from reported consumption and fish-
ing sites and from the PCDD/PCDF blood
concentrations with fairly good agreement.
Calculations of average weekly exposures
from body burdens show that about halfof
the crab consumers exceeded the Nordic
TWI of35 pg TEQ/kg body weight/week,
but only a few slightly exceeded the WHO
TWI of70 pgTEQ/kg bodyweight/week.
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